retatrutide peptide obesity triple hormone receptor agonist First-in-Class 'Triple-G'! Retatrutide, a first-in-class GIP, GLP-1 & Glucagon drug leads to nearly 29% weight loss in first pivotal test! Eli Lilly announced positive topline results from the triple hormone receptor agonist retatrutide

Therefore, GPs, endoscopists and gastroenterologists will increasingly be called on to manage the GI side effects of these drugs and possibly the consequences of rapid weight loss and nutritional deficiencies

Lets dive into it right now

Moreover, these anti-inflammatory properties also extend to the neuro-ophthalmic circuit, which is embryonically related to the central nervous system and is thus similarly afflicted by pathologies driven by inflammation

Nuclear factor-kappa B (NF-B) is a transcription factor that binds DNA and induces the transcription of the COX-2 gene, other pro-inflammatory genes, as well as genes involved in cell proliferation, adhesion, survival, and differentiation

Brian Wojeck, MD, MPH, Assistant Professor of Medicine (Endocrinology), Yale School of Medicine, said that because GLP-1 medications treat the primary disease of obesity, they have important effects on obesity-related comorbidities

Pricing is comparable, though Henry Meds may differ on specific medication options and pharmacy partnerships